Here you can find a continually updated listing of Memorial Sloan-Kettering’s current clinical trials for pancreatic cancer. To learn more about a study, choose from the list below.
Title |
Investigator |
|---|---|
|
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors [Protocol 11-117] |
Schwartz, Gary, MD |
|
A Phase II Study of CO-1.01 for Gemcitabine-Refractory Patients with Stage IV Pancreatic Cancer [Protocol 10-210] |
O'Reilly, Eileen, MD |
|
A Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin in Patients with Potentially Resectable Previously Untreated Pancreatic Adenocarcinoma [Protocol 07-113] |
O'Reilly, Eileen, MD |
|
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Pancreatic Cancer [Protocol 10-083] |
Goodman, Karyn, MD |
|
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy [Protocol 11-194] |
Ginex, Pamela, RN, EDD |
|
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry [Protocol 02-102] |
Kurtz, Robert, MD |
